Table 2.
Description of viral coinfection in the Pj positive group and the negative control group (2017–2019).
| Pj Positive Group | Negative Control Group | p | ||||||
|---|---|---|---|---|---|---|---|---|
| n | % | 95% CI | n | % | 95% CI | |||
| Child characteristics | ||||||||
| Number of children | 13 | 31 | ||||||
| Sex ratio (M/F) | 0.86 | 1.21 | ||||||
| Mean age (months) | 7.3 | 10.39 | ||||||
| Birth term | >37 WG | 10 | 76.9 | 23 | 74.2 | |||
| 32–37 WG | 3 | 23.1 | 3 | 9.7 | ||||
| 28–32 WG | 0 | 0 | 2 | 6.5 | ||||
| <28 WG | 0 | 0 | 3 | 9.7 | ||||
| HIV-positive | 0 | 0 | 0 | 0 | ||||
| Viral respiratory pathogens | ||||||||
| Number of children with viral respiratory pathogens | 7 | 53.9 | 0.2513–0.8078 | 14 | 45.2 | 0.2732–0.6397 | 0.7438 | |
| Rhinovirus | 6 | 85.71 | 0.4213–0.9964 | 10 | 71.4 | 0.4190–0.9161 | 0.4964 | |
| Adenovirus | 1 | 14.3 | 0.0036–0.5787 | 5 | 35.7 | 0.1276–0.6486 | 0.6523 | |
| Parainfluenza Virus | 0 | 0 | 2 a | 14.3 | 0.0178–0.4281 | 1.0000 | ||
| Coronavirus | 0 | 0 | 1 b | 7.1 | 0.0018–0.3387 | 1.0000 | ||
| Metapneumovirus | 0 | 0 | 1 | 7.1 | 0.0018–0.3387 | 1.0000 | ||
| Enterovirus | 2 | 28.6 | 0.0367–0.7096 | 0 | 0 | 0.0825 | ||
| Respiratory Syncytial Virus | 2 | 28.6 | 0.0367–0.7096 | 0 | 0 | 0.0825 | ||
| Number of children without viral respiratory pathogens | 6 | 46.2 | 17 | 54.8 | ||||
Pj: Pneumocystis jirovecii; CI: Confidence interval; M: Male; F: Female; WG: Week of gestation; HIV: Human immunodeficiency virus. a Parainfluenzae type 1 (n = 1) and type 3 (n = 1); b Coronavirus E229.